384 related articles for article (PubMed ID: 12463476)
41. Depletion of alloantigen-primed lymphocytes overcomes resistance to allogeneic bone marrow in mildly conditioned recipients.
Prigozhina TB; Elkin G; Gurevitch O; Morecki S; Yakovlev E; Khitrin S; Slavin S
Blood Cells Mol Dis; 2004; 33(3):238-47. PubMed ID: 15528138
[TBL] [Abstract][Full Text] [Related]
42. Ex vivo fludarabine exposure inhibits graft-versus-host activity of allogeneic T cells while preserving graft-versus-leukemia effects.
Giver CR; Montes RO; Mittelstaedt S; Li JM; Jaye DL; Lonial S; Boyer MW; Waller EK
Biol Blood Marrow Transplant; 2003 Oct; 9(10):616-32. PubMed ID: 14569558
[TBL] [Abstract][Full Text] [Related]
43. Prevention of diabetes in nonobese diabetic mice by nonmyeloablative allogeneic bone marrow transplantation.
Elkin G; Prigozhina TB; Slavin S
Exp Hematol; 2004 Jun; 32(6):579-84. PubMed ID: 15183899
[TBL] [Abstract][Full Text] [Related]
44. A nonlethal conditioning approach to achieve durable multilineage mixed chimerism and tolerance across major, minor, and hematopoietic histocompatibility barriers.
Colson YL; Wren SM; Schuchert MJ; Patrene KD; Johnson PC; Boggs SS; Ildstad ST
J Immunol; 1995 Nov; 155(9):4179-88. PubMed ID: 7594573
[TBL] [Abstract][Full Text] [Related]
45. Influence of the additional injection of host-type bone marrow on the immune tolerance of minor antigen-mismatched chimeras: possible involvement of double-negative (natural killer) T cells.
Sefrioui H; Billiau AD; Overbergh L; Rutgeerts O; Waer M
Transplantation; 1999 Nov; 68(10):1560-7. PubMed ID: 10589955
[TBL] [Abstract][Full Text] [Related]
46. Specific immunosuppression by mixed chimerism with bone marrow transplantation after Staphylococcal Enterotoxin B pretreatment could prolong corneal allograft survival in mice.
Zhang Y; Pan Z; Chen Y; Jie Y; He Y
Mol Vis; 2012; 18():974-82. PubMed ID: 22550390
[TBL] [Abstract][Full Text] [Related]
47. Complete allogeneic hematopoietic chimerism achieved by a combined strategy of in utero hematopoietic stem cell transplantation and postnatal donor lymphocyte infusion.
Hayashi S; Peranteau WH; Shaaban AF; Flake AW
Blood; 2002 Aug; 100(3):804-12. PubMed ID: 12130490
[TBL] [Abstract][Full Text] [Related]
48. Allogeneic intra-BM-BMT plus adult thymus transplantation from same donor has benefits for long-term survival even after sublethal irradiation or low-dose BM cell injection.
Nishida T; Hosaka N; Takaki T; Miyake T; Cui W; Inaba M; Kinoshita H; Matsuda T; Ikehara S
Bone Marrow Transplant; 2009 Jun; 43(11):829-37. PubMed ID: 19079314
[TBL] [Abstract][Full Text] [Related]
49. Allogeneic versus semiallogeneic F1 bone marrow transplantation into sublethally irradiated MHC-disparate hosts. Effects on mixed lymphoid chimerism, skin graft tolerance, host survival, and alloreactivity.
Pierce GE
Transplantation; 1990 Jan; 49(1):138-44. PubMed ID: 2137269
[TBL] [Abstract][Full Text] [Related]
50. Additional monoclonal antibody (mAB) injections can replace thymic irradiation to allow induction of mixed chimerism and tolerance in mice receiving bone marrow transplantation after conditioning with anti-T cell mABs and 3-Gy whole body irradiation.
Tomita Y; Sachs DH; Khan A; Sykes M
Transplantation; 1996 Feb; 61(3):469-77. PubMed ID: 8610363
[TBL] [Abstract][Full Text] [Related]
51. Effect of Ex Vivo-Expanded Recipient Regulatory T Cells on Hematopoietic Chimerism and Kidney Allograft Tolerance Across MHC Barriers in Cynomolgus Macaques.
Duran-Struuck R; Sondermeijer HP; Bühler L; Alonso-Guallart P; Zitsman J; Kato Y; Wu A; McMurchy AN; Woodland D; Griesemer A; Martinez M; Boskovic S; Kawai T; Cosimi AB; Yang YG; Hu Z; Wuu CS; Slate A; Mapara M; Baker S; Tokarz R; D'Agati V; Hammer S; Pereira M; Lipkin WI; Wekerle T; Levings M; Sykes M
Transplantation; 2017 Feb; 101(2):274-283. PubMed ID: 27846155
[TBL] [Abstract][Full Text] [Related]
52. Durable mixed allogeneic chimerism and tolerance by a nonlethal radiation-based cytoreductive approach.
Colson YL; Li H; Boggs SS; Patrene KD; Johnson PC; Ildstad ST
J Immunol; 1996 Oct; 157(7):2820-9. PubMed ID: 8816385
[TBL] [Abstract][Full Text] [Related]
53. [Establishment of nonmyeloablative allogeneic stem cell transplantation model in H-2 haploidentical mice and its related study].
Li JJ; Zhang Y; Zhang MW; Hou CM; Wu Y; Mao N; Ai HS
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Oct; 12(5):655-60. PubMed ID: 15498129
[TBL] [Abstract][Full Text] [Related]
54. Requirements for the promotion of allogeneic engraftment by anti-CD154 (anti-CD40L) monoclonal antibody under nonmyeloablative conditions.
Taylor PA; Lees CJ; Waldmann H; Noelle RJ; Blazar BR
Blood; 2001 Jul; 98(2):467-74. PubMed ID: 11435318
[TBL] [Abstract][Full Text] [Related]
55. Enhancement of allogeneic hematopoietic stem cell engraftment and prevention of GVHD by intra-bone marrow bone marrow transplantation plus donor lymphocyte infusion.
Nakamura K; Inaba M; Sugiura K; Yoshimura T; Kwon AH; Kamiyama Y; Ikehara S
Stem Cells; 2004; 22(2):125-34. PubMed ID: 14990852
[TBL] [Abstract][Full Text] [Related]
56. Regulation of alloresponses after bone marrow transplantation using donor T cells expressing a thymidine kinase suicide gene.
Drobyski WR; Gendelman M
Leuk Lymphoma; 2002 Oct; 43(10):2011-6. PubMed ID: 12481900
[TBL] [Abstract][Full Text] [Related]
57. Effect of lethal total body irradiation on bone marrow chimerism, acute graft-versus-host disease, and tumor engraftment in mouse models: impact of different radiation techniques using low- and high-energy X-rays.
To NH; Pilon C; Moatti A; Debesset A; Debbi K; Coraggio G; Ksouri W; Massaria V; Cohen JL; Belkacemi Y; Thiolat A
Strahlenther Onkol; 2023 Dec; 199(12):1242-1254. PubMed ID: 36932237
[TBL] [Abstract][Full Text] [Related]
58. Addition of cyclophosphamide to T-cell depletion-based nonmyeloablative conditioning allows donor T-cell engraftment and clonal deletion of alloreactive host T-cells after bone marrow transplantation.
Xu H; Chilton PM; Huang Y; Schanie CL; Yan J; Ildstad ST
Transplantation; 2007 Apr; 83(7):954-63. PubMed ID: 17460568
[TBL] [Abstract][Full Text] [Related]
59. Adoptive immunotherapy in canine mixed chimeras after nonmyeloablative hematopoietic cell transplantation.
Georges GE; Storb R; Thompson JD; Yu C; Gooley T; Bruno B; Nash RA
Blood; 2000 May; 95(10):3262-9. PubMed ID: 10807798
[TBL] [Abstract][Full Text] [Related]
60. Therapeutic efficacy of polyclonal tregs does not require rapamycin in a low-dose irradiation bone marrow transplantation model.
Pilat N; Klaus C; Gattringer M; Jaeckel E; Wrba F; Golshayan D; Baranyi U; Wekerle T
Transplantation; 2011 Aug; 92(3):280-8. PubMed ID: 21697774
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
